|
|
(One intermediate revision not shown.) |
Line 1: |
Line 1: |
| | | |
| ==SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO MGREGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 7 STRUCTURES== | | ==SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO MGREGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 7 STRUCTURES== |
- | <StructureSection load='1cvq' size='340' side='right'caption='[[1cvq]], [[NMR_Ensembles_of_Models | 7 NMR models]]' scene=''> | + | <StructureSection load='1cvq' size='340' side='right'caption='[[1cvq]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[1cvq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1CVQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1CVQ FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[1cvq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1CVQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1CVQ FirstGlance]. <br> |
- | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=DAR:D-ARGININE'>DAR</scene>, <scene name='pdbligand=DGL:D-GLUTAMIC+ACID'>DGL</scene>, <scene name='pdbligand=DIL:D-ISOLEUCINE'>DIL</scene>, <scene name='pdbligand=MGG:2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO-PENTANOIC+ACID'>MGG</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1cs9|1cs9]], [[1ct6|1ct6]]</td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DAR:D-ARGININE'>DAR</scene>, <scene name='pdbligand=DGL:D-GLUTAMIC+ACID'>DGL</scene>, <scene name='pdbligand=DIL:D-ISOLEUCINE'>DIL</scene>, <scene name='pdbligand=MGG:2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO-PENTANOIC+ACID'>MGG</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1cvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1cvq OCA], [http://pdbe.org/1cvq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1cvq RCSB], [http://www.ebi.ac.uk/pdbsum/1cvq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1cvq ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1cvq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1cvq OCA], [https://pdbe.org/1cvq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1cvq RCSB], [https://www.ebi.ac.uk/pdbsum/1cvq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1cvq ProSAT]</span></td></tr> |
| </table> | | </table> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
Line 22: |
Line 22: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Briand, J P]] | + | [[Category: Briand JP]] |
- | [[Category: Cung, M T]] | + | [[Category: Cung MT]] |
- | [[Category: Du, A Phan Chan]]
| + | [[Category: Guichard G]] |
- | [[Category: Guichard, G]] | + | [[Category: Muller S]] |
- | [[Category: Muller, S]] | + | [[Category: Petit MC]] |
- | [[Category: Petit, M C]] | + | [[Category: Phan Chan Du A]] |
- | [[Category: Antigen- antibody complex]] | + | |
- | [[Category: Dna binding protein]]
| + | |
- | [[Category: Pseudomimetic]]
| + | |
- | [[Category: Retro-inverso analogue]]
| + | |
- | [[Category: Synthetic peptide]]
| + | |
- | [[Category: Tr-noe]]
| + | |
| Structural highlights
Publication Abstract from PubMed
The three-dimensional structures of the two L-peptides, H-CGGIRGERA-OH, called L(A), and H-CGGIRGERG-OH, called L(G), corresponding or close to the IRGERA sequence present in the C-terminal region (residues 130-135) of histone H3, and their retro-inverso analogues HO-mAreGriGGC-NH2, called RI(mA), and HO-mGreGriGGC-NH2, called RI(mG), have been studied by two-dimensional 1H NMR and molecular dynamics calculations in association with a monoclonal antibody generated against L(A). At 25 degrees C, the affinity constants of the monoclonal antibody with respect to RI(mA) and RI(mG) were 75- and 270-fold higher than those measured with the homologous L(A) and L(G) peptides, respectively. Due to the spontaneous epimerization of the mA malonic residue, RI(mA) gave rise to two sets of resonances. With regard to the NH amide region, one set was similar to that for RI(mG) while the second was similar to those for the parent L-peptides L(A) and L(G). The antibody-bound conformations of the two couples of L- and retro-inverso peptides have been analyzed using molecular modeling calculations based on the transferred NOE interproton distances. Folded structures appeared in both cases with a type II' beta-turn in the parent GGIR sequence and a type I' beta-turn in the retro-inverso reGr sequence.
Structure of antibody-bound peptides and retro-inverso analogues. A transferred nuclear Overhauser effect spectroscopy and molecular dynamics approach.,Phan-Chan-Du A, Petit MC, Guichard G, Briand JP, Muller S, Cung MT Biochemistry. 2001 May 15;40(19):5720-7. PMID:11341837[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Phan-Chan-Du A, Petit MC, Guichard G, Briand JP, Muller S, Cung MT. Structure of antibody-bound peptides and retro-inverso analogues. A transferred nuclear Overhauser effect spectroscopy and molecular dynamics approach. Biochemistry. 2001 May 15;40(19):5720-7. PMID:11341837
|